Frontiers in Clinical Drug Research - Alzheimer Disorders is a book series concerned with Alzheimer;s disease (AD), a disease that causes dementia, or loss of brain function. This disease affects parts of the brain that affect memory, thought, and language. Chapters in each volume focus on drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.<br/> <br/>Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in the field of Alzheimer’s disease research.<br/> <br/>The seventh volume of this series features chapters covering critical discussions on AD biochemistry and new therapies. The reviews in this volume include:<br/>- Deep Brain Stimulation in the Treatment of Alzheimer;s disease<br/>- ASS234: A New and Promising Anti-Alzheimer Agent<br/>- Recent Advances in Alzheimer;s Drug Discovery Research<br/>- Alzheimer’s Disease and Proteasome: The Therapeutic Development and Management<br/>- Alzheimer´s Disease: Fundamental Concepts, Novel Findings and Therapeutics Outcomes Coming from the Ca2+/cAMP Signalling Interaction<br/>- Alzheimer;s Disease: An Approach for Non-Pharmacological Therapies<br/>- Past and Present Drug Development for Alzheimer;s Disease.<br/>